AU6158700A - Vaccine - Google Patents

Vaccine

Info

Publication number
AU6158700A
AU6158700A AU61587/00A AU6158700A AU6158700A AU 6158700 A AU6158700 A AU 6158700A AU 61587/00 A AU61587/00 A AU 61587/00A AU 6158700 A AU6158700 A AU 6158700A AU 6158700 A AU6158700 A AU 6158700A
Authority
AU
Australia
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61587/00A
Other languages
English (en)
Inventor
Teresa Cabezon Silva
Davin Clifford Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Corixa Corp
Original Assignee
SmithKline Beecham Biologicals SA
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/352,616 external-priority patent/US6395278B1/en
Priority claimed from US09/439,313 external-priority patent/US6329505B1/en
Priority claimed from US09/570,737 external-priority patent/US7202342B1/en
Priority claimed from US09/593,793 external-priority patent/US7517952B1/en
Priority claimed from GB0015747A external-priority patent/GB0015747D0/en
Application filed by SmithKline Beecham Biologicals SA, Corixa Corp filed Critical SmithKline Beecham Biologicals SA
Publication of AU6158700A publication Critical patent/AU6158700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU61587/00A 1999-07-13 2000-07-11 Vaccine Abandoned AU6158700A (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US09/352,616 US6395278B1 (en) 1997-02-25 1999-07-13 Prostate specific fusion protein compositions
US09352616 1999-07-13
US09439313 1999-11-12
US09/439,313 US6329505B1 (en) 1997-02-25 1999-11-12 Compositions and methods for therapy and diagnosis of prostate cancer
US44368699A 1999-11-18 1999-11-18
US09443686 1999-11-18
US48367200A 2000-01-14 2000-01-14
US09483672 2000-01-14
US53685700A 2000-03-27 2000-03-27
US09536857 2000-03-27
US56810000A 2000-05-09 2000-05-09
US09568100 2000-05-09
US09570737 2000-05-12
US09/570,737 US7202342B1 (en) 1999-11-12 2000-05-12 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/593,793 US7517952B1 (en) 1997-02-25 2000-06-13 Compositions and methods for the therapy and diagnosis of prostate cancer
US09593793 2000-06-13
US60578300A 2000-06-27 2000-06-27
US09605783 2000-06-27
GB0015747 2000-06-27
GB0015747A GB0015747D0 (en) 2000-06-27 2000-06-27 Vaccine
PCT/EP2000/006618 WO2001004143A2 (fr) 1999-07-13 2000-07-11 Vaccin

Publications (1)

Publication Number Publication Date
AU6158700A true AU6158700A (en) 2001-01-30

Family

ID=27579342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61587/00A Abandoned AU6158700A (en) 1999-07-13 2000-07-11 Vaccine

Country Status (5)

Country Link
EP (1) EP1194571A1 (fr)
JP (1) JP2003504080A (fr)
AU (1) AU6158700A (fr)
CA (1) CA2378846A1 (fr)
WO (1) WO2001004143A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022497B1 (en) 1999-03-11 2006-04-04 Mt. Sinai Hospital Human kallikrein-like genes
EP1220931A1 (fr) * 1999-10-07 2002-07-10 Schering Aktiengesellschaft Adn codant le polypeptide prost 07
ES2333579T3 (es) * 2000-06-20 2010-02-24 Corixa Corporation Proteinas de fusion de mycobacterium tuberculosis.
GB0015736D0 (en) * 2000-06-27 2000-08-16 Smithkline Beecham Biolog Vaccine
GB0015722D0 (en) * 2000-06-27 2000-08-16 Smithkline Beecham Sa Vaccine
WO2009046739A1 (fr) * 2007-10-09 2009-04-16 Curevac Gmbh Composition pour traiter le cancer de la prostate (pca)
WO2010037408A1 (fr) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprenant un arnm complexé et un arnm nu pour déclencher ou augmenter une réponse immunostimulante chez un mammifère et utilisations de ladite composition
WO2011009173A1 (fr) * 2009-07-23 2011-01-27 Mater Medical Research Institute Immunothérapie des cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78869T1 (de) * 1985-02-07 1992-08-15 Smithkline Beecham Corp Malaria-impfstoff.
US5786148A (en) * 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
HUP0002095A3 (en) * 1997-02-25 2002-02-28 Corixa Corp Seattle Compounds for immunotherapy of prostate cancer and methods for their use
IL140845A0 (en) * 1998-07-14 2002-02-10 Corixa Corp Compositions for therapy and diagnosis of prostate cancer

Also Published As

Publication number Publication date
JP2003504080A (ja) 2003-02-04
EP1194571A1 (fr) 2002-04-10
WO2001004143A3 (fr) 2001-10-11
CA2378846A1 (fr) 2001-01-18
WO2001004143A2 (fr) 2001-01-18

Similar Documents

Publication Publication Date Title
IL145045A0 (en) Vaccine
HUS1300072I1 (hu) Vakcina
AU5977700A (en) Vaccines
AU2023701A (en) Sketcher
AU1600401A (en) Malaria vaccine
AU6158700A (en) Vaccine
AU5811600A (en) Vaccine
GB9906437D0 (en) Vaccine
AU1901801A (en) Glucofuranoses
AU1915601A (en) Periotome
AU5084300A (en) New vaccine formulations - 1
AU1101701A (en) Vaccine compositions
AU2197301A (en) Microlamp
AU4935700A (en) New vaccine formulations-3
AU2153801A (en) Idiotype vaccines
AU1737601A (en) Collectalbum
GB9909072D0 (en) Vaccine
AU1890101A (en) Ikk4
AU2001285773A1 (en) Vaccine
AUPQ245999A0 (en) Vaccine strategy
GB9904408D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9925619D0 (en) Vaccine
GB9925618D0 (en) Vaccine
GB9922703D0 (en) Vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase